{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:00:59Z","timestamp":1740117659220,"version":"3.37.3"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.leukres.2024.107594","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T06:21:10Z","timestamp":1726640470000},"page":"107594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Strategies to overcome splicing variants interference in mutational testing for BCR::ABL1 KD"],"prefix":"10.1016","volume":"146","author":[{"given":"Juliana","family":"Bulchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Blajberg","family":"Schaffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Sabioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telma Fran\u00e7a","family":"Padilha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Camile","family":"Silva de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Trevizani","family":"Stelzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Zalcberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Mayumi","family":"Gutiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2024.107594_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/hematology.2023000447","article-title":"Resistance mutations in CML and how we approach them","volume":"2023","author":"Soverini","year":"2023","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.leukres.2024.107594_bib2","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.3390\/jcm9123865","article-title":"Molecular testing in CML between old and new methods: are we at a turning point?","volume":"9","author":"Soverini","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.leukres.2024.107594_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12032-010-9781-z","article-title":"BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?","volume":"29","author":"Gruber","year":"2012","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2024.107594_bib4","first-page":"3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate\u2013binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.","volume":"99","author":"Branford","year":"2002","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"11","key":"10.1016\/j.leukres.2024.107594_bib5","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1158\/1535-7163.MCT-10-0595","article-title":"Exon 7 deletion in the bcr-abl gene is frequent in chronic myeloid leukemia patients and is not correlated with resistance against imatinib","volume":"9","author":"Gaillard","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2024.107594_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.14023","article-title":"Pitfalls in molecular standardization for detection of FLT3-ITD in acute myeloid leukemia","author":"da Costa","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"issue":"9","key":"10.1016\/j.leukres.2024.107594_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1179\/1607845415Y.0000000009","article-title":"A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms","volume":"20","author":"Yao","year":"2015","journal-title":"Hematology"},{"issue":"11","key":"10.1016\/j.leukres.2024.107594_bib8","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/cas.13353","article-title":"Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response.","volume":"108","author":"Yuda","year":"2017","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.leukres.2024.107594_bib9","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/cas.14424","article-title":"Tyrosine kinase inhibitors induce alternative spliced BCR-ABLIns35bp variant via inhibition of RNA polymerase II on genomic BCR-ABL.","volume":"111","author":"Yuda","year":"2020","journal-title":"Cancer Sci."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T17:48:40Z","timestamp":1729878520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":9,"alternative-id":["S0145212624001607"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107594","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to overcome splicing variants interference in mutational testing for BCR::ABL1 KD","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107594"}}